The drug manufacturer's patent on Cipro was upheld in yesterday a U.S. federal court. Several generic drug companies wanted to make versions of the drug before Bayer's patent expires next year.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan